Brinker Capital Investments’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-84,693
| Closed | -$798K | – | 1909 |
|
|
2024
Q4 | $798K | Sell |
84,693
-7,955
| -9% | -$74.9K | 0.01% | 1159 |
|
|
2024
Q3 | $989K | Sell |
92,648
-54,140
| -37% | -$578K | 0.01% | 1039 |
|
|
2024
Q2 | $1.46M | Sell |
146,788
-5,399
| -4% | -$53.6K | 0.02% | 798 |
|
|
2024
Q1 | $1.79M | Buy |
152,187
+12,559
| +9% | +$148K | 0.02% | 709 |
|
|
2023
Q4 | $1.96M | Sell |
139,628
-14,731
| -10% | -$207K | 0.02% | 643 |
|
|
2023
Q3 | $1.88M | Sell |
154,359
-5,157
| -3% | -$62.7K | 0.02% | 642 |
|
|
2023
Q2 | $2M | Sell |
159,516
-5,476
| -3% | -$68.8K | 0.02% | 651 |
|
|
2023
Q1 | $1.83M | Buy |
164,992
+652
| +0.4% | +$7.23K | 0.02% | 633 |
|
|
2022
Q4 | $2.01M | Buy |
164,340
+39,293
| +31% | +$480K | 0.04% | 483 |
|
|
2022
Q3 | $1.31M | Buy |
125,047
+19,860
| +19% | +$207K | 0.03% | 601 |
|
|
2022
Q2 | $1.13M | Buy |
105,187
+3,703
| +4% | +$39.8K | 0.02% | 690 |
|
|
2022
Q1 | $961K | Sell |
101,484
-35,339
| -26% | -$335K | 0.01% | 808 |
|
|
2021
Q4 | $1.58M | Buy |
136,823
+38,095
| +39% | +$440K | 0.02% | 659 |
|
|
2021
Q3 | $952K | Hold |
98,728
| – | – | 0.02% | 792 |
|
|
2021
Q2 | $952K | Buy |
98,728
+21,865
| +28% | +$211K | 0.01% | 846 |
|
|
2021
Q1 | $759K | Buy |
+76,863
| New | +$759K | 0.01% | 781 |
|